Erratum: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients (Oncotarget (2017) 8 (81285-81294) DOI: 10.18632/oncotarget.18150)

Lihui Qu, Yingying Lu, Meike Ying, Bingjue Li, Chunhua Weng, Zhoutao Xie, Ludan Liang, Chuan Lin, Xian Yang, Shi Feng, Yucheng Wang, Xiujin Shen, Qin Zhou, Ying Chen, Zhimin Chen, Jianyong Wu, Weiqiang Lin, Yi Shen, Jing Qin, Hang XuFeng Xu, Junwen Wang, Jianghua Chen, Hong Jiang, Hongfeng Huang

Research output: Contribution to journalComment/debatepeer-review

Abstract

This article has been corrected: In Figures 1, 2, 3 and 4, the word 'mouth' was mistakenly used instead of 'month'. The corrected Figures are shown below. The authors declare that these corrections do not change the results or conclusions of this paper. (Figure Presented).

Original languageEnglish (US)
Pages (from-to)1474-1477
Number of pages4
JournalOncotarget
Volume11
Issue number16
StatePublished - Apr 21 2020

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Erratum: Tacrolimus dose requirement based on the CYP3A5 genotype in renal transplant patients (Oncotarget (2017) 8 (81285-81294) DOI: 10.18632/oncotarget.18150)'. Together they form a unique fingerprint.

Cite this